Incannex Healthcare (IXHL) Revenue (2024)
Incannex Healthcare (IXHL) posted Revenue of $12000.0 for Q4 2024, down 83.78% sequentially from $74000.0 in Q3 2024.
Incannex Healthcare (IXHL) Revenue (2024) Analysis & Trends
Incannex Healthcare has reported Revenue for 1 years, with the latest figure at $12000.0 in Q4 2024.
- Quarterly Revenue changed N/A year-over-year to $12000.0 in Q4 2024, while the trailing twelve-month figure through Jun 2025 was $86000.0 (changed N/A YoY) and the FY2025 annual result came in at $86000.0, up 616.67% from the prior year.
- Revenue retreated to $12000.0 in Q4 2024 per IXHL's latest filing, from $74000.0 in the prior quarter.
- Over five years, Revenue peaked at $74000.0 in Q3 2024 and troughed at $12000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Incannex Healthcare | 41.37 Mn | 41.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 74,000.00 |